TCR2 Therapeutics Inc. TCRR
Set alert
1.48 +1.48 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 58.11M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -0.60
- Beta
- 1.93
- Short ratio
- 1.29
- Inst. own
- 54.32%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 11, 2023
- 50-d avg
- 1.69
- 200-d avg
- 1.56
- 1y target
- 6.43
1Y chart
Events in this range
- Aug 8, 2022Earnings: —; estimate -0.77; surprise —%
- Nov 8, 2022Earnings: —; estimate -0.83; surprise —%
- Jan 6, 2023Rating: Piper Sandler · — → Overweight
- Mar 7, 2023Downgrade: HC Wainwright & Co. · Buy → Neutral
- Mar 8, 2023Downgrade: Truist Securities · Buy → Hold
- Mar 9, 2023Downgrade: Jefferies · Buy → Underperform
- Mar 23, 2023Rating: EF Hutton · — → Hold
- Mar 23, 2023Earnings: —; estimate -0.8; surprise —%
- Mar 24, 2023Downgrade: Mizuho · Buy → Neutral
- May 11, 2023Earnings: —; estimate -0.76; surprise —%
Signals (34)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | May 31, 2023 | 3 years ago |
| SMA: Bearish | May 26, 2023 | 3 years ago |
| SMA: Bearish | May 26, 2023 | 3 years ago |
| MACD: Sell Signal | May 16, 2023 | 3 years ago |
| RSI: Overbought | May 5, 2023 | 3 years ago |
| SMA: Bullish | May 1, 2023 | 3 years ago |
| RSI: Overbought | Apr 24, 2023 | 3 years ago |
| MACD: Buy Signal | Apr 14, 2023 | 3 years ago |
| MACD: Sell Signal | Mar 23, 2023 | 3 years ago |
| MACD: Buy Signal | Mar 6, 2023 | 3 years ago |
| SMA: Bearish | Mar 2, 2023 | 3 years ago |
| SMA: Bullish | Feb 28, 2023 | 3 years ago |
| MACD: Sell Signal | Feb 7, 2023 | 3 years ago |
| RSI: Overbought | Jan 27, 2023 | 3 years ago |
| SMA: Bullish | Jan 11, 2023 | 3 years ago |
| MACD: Buy Signal | Dec 29, 2022 | 3 years ago |
| RSI: Oversold | Dec 12, 2022 | 3 years ago |
| MACD: Sell Signal | Dec 9, 2022 | 3 years ago |
| RSI: Oversold | Nov 21, 2022 | 3 years ago |
| RSI: Oversold | Nov 2, 2022 | 3 years ago |
| RSI: Oversold | Oct 27, 2022 | 4 years ago |
| MACD: Buy Signal | Oct 4, 2022 | 4 years ago |
| RSI: Oversold | Sep 16, 2022 | 4 years ago |
| RSI: Oversold | Sep 1, 2022 | 4 years ago |
| SMA: Bearish | Aug 26, 2022 | 4 years ago |
| SMA: Bullish | Aug 24, 2022 | 4 years ago |
| SMA: Bearish | Aug 19, 2022 | 4 years ago |
| MACD: Sell Signal | Aug 19, 2022 | 4 years ago |
| SMA: Bearish | Aug 18, 2022 | 4 years ago |
| RSI: Overbought | Aug 11, 2022 | 4 years ago |
| MACD: Buy Signal | Aug 10, 2022 | 4 years ago |
| MACD: Sell Signal | Jul 20, 2022 | 4 years ago |
| RSI: Overbought | Jul 6, 2022 | 4 years ago |
| SMA: Bullish | Jun 6, 2022 | 4 years ago |
Compare TCRR
Chart and line up TCRR against other symbols or a saved comparison set.
- TCRR TCR2 Therapeutics Inc.
1.48
+1.48 —
- SPY State Street SPDR S&P 500 ETF Trust
755.72
-13.64 -1.77%
- QQQ Invesco QQQ Trust
690.49
-24.85 -3.47%
Sign in to keep these symbols in a saved comparison set.
| Metric | TCRR | SPY | QQQ |
|---|---|---|---|
| Last price | 1.48 | 755.72 | 690.49 |
| Change | +1.48 | -13.64 | -24.85 |
| Change % | — | -1.77% | -3.47% |
| Open | 0.00 | 761.38 | 697.13 |
| Day high | 0.00 | 761.46 | 698.63 |
| Day low | 0.00 | 750.36 | 683.45 |
| Previous close | 0.00 | 769.36 | 715.34 |
| Volume | 0 | 77.70M | 85.24M |
| Average volume | 0 | 41.22M | 34.57M |
| Market cap | 58.11M | 812.08B | 483.28B |
| P/E ratio | 0.00 | 23.99 | 26.44 |
| Earnings per share | 0.00 | 31.50 | 26.12 |
| Dividend yield | — | 0.00 | 0.00 |
| 52-week high | 0.00 | 779.09 | 759.66 |
| 52-week low | 0.00 | 631.97 | 558.28 |
| 1-week return | — | -0.559233% | -1.97% |
| 1-month return | — | -0.906075% | -6.66% |
| 3-month return | — | +1.89% | +1.02% |
| 6-month return | — | +5.16% | +3.41% |
| Year-to-date return | — | +10.82% | +12.40% |
| 1-year return | — | +11.16% | +10.29% |
| 2-year return | — | +32.90% | +42.71% |
| 50-day moving average | 0.00 | 767.63 | 725.41 |
| 200-day moving average | 0.00 | 728.53 | 679.17 |
| Target price | 6.43 | — | — |
| Beta | 1.93 | 0.00 | 0.00 |
| Short ratio | 1.29 | — | — |
| Institutional ownership | 54.32% | — | — |